National Healthcare
131 hedge funds and large institutions have $469M invested in National Healthcare in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 15 closing their positions.
229% more call options, than puts
Call options by funds: $332K | Put options by funds: $101K
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
10% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 41
1% more funds holding
Funds holding: 130 → 131 (+1)
0.28% less ownership
Funds ownership: 45.03% → 44.76% (-0.28%)
3% less capital invested
Capital invested by funds: $486M → $469M (-$17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$3.78M |
| 2 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$2.49M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$1.01M |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$969K |
| 5 |
DIA
Dean Investment Associates
Beavercreek,
Ohio
|
+$570K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.23M |
| 2 |
CA
Calton & Associates
Tampa,
Florida
|
-$2.52M |
| 3 |
Renaissance Technologies
New York
|
-$1.63M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.61M |
| 5 |
Goldman Sachs
New York
|
-$1.39M |
NHC Hedge Fund Activity: Q4 2021 in Review
131 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q4 2021, worth a combined $469M — down 3.5% from $486M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new NHC positions and 15 closed out — a net gain of 2 holders — while 45 added to existing stakes and 41 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $3.78M. The largest seller was Arrowstreet Capital, cutting an estimated $3.23M.
- 131 institutional investors held National Healthcare (NHC) as of Q4 2021, up from 130 in Q3 2021.
- Funds reported $469M of National Healthcare stock for Q4 2021, down 3.5% quarter-over-quarter.
- 17 funds opened new National Healthcare positions in Q4 2021 and 15 closed out, a net change of +2 holders.
- The largest National Healthcare buyer in Q4 2021 was JP Morgan Chase, an estimated $3.78M added.
- The largest National Healthcare seller in Q4 2021 was Arrowstreet Capital, an estimated $3.23M sold.
Based on aggregated 13F filings for Q4 2021.